N Sakuragawa

Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.

Takaki Koide, Shoji Odani, Kaoru Takahashi et al. · Proceedings of the National Academy of Sciences · 1984 · 221 citations · Full text

Medicine, Hematology, Molecular Biology +13

Hypoproduction of erythropoietin contributes to anemia in chronic cadmium intoxication: clinical study on Itai-itai disease in Japan

Hyogo Horiguchi, Hidetoyo Teranishi, Kenji Niiya et al. · Archives of Toxicology · 1994 · 134 citations

Pharmacy, Hematology, Toxicology +16

Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC) - a multicenter co-operative double-blind trial in comparison with heparin -

N Sakuragawa, Hiroshi Hasegawa, Masahiro Maki et al. · Thrombosis Research · 1993 · 117 citations

Medicine, Hematology, Surgery +14

Inhibition of thrombin by sulfated polysaccharides isolated from green algae

Yumiko Hayakawa, Toshimitsu Hayashi, Jung‐Bum Lee et al. · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · 2000 · 93 citations

Life Sciences, Biochemistry, Botany +14

Antithrombin III toyama: A hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitis

N Sakuragawa, Kaoru Takahashi, Shinichi Kondo et al. · Thrombosis Research · 1983 · 74 citations

Medicine, Hematology, Internal Medicine +11